Quang X. Pham
CEO and Chairman at Cadrenal Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Cadrenal Therapeutics Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Cadrenal Therapeutics Inc. October 20, 202399.9%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 29, 2026 | Cadrenal Therapeutics Inc. | Open-market sale | −7,400 | $3.03 | $22,422 |
| Jun 26, 2026 | Cadrenal Therapeutics Inc. | Open-market sale | −9,029 | $3.05 | $27,538 |
| Jun 25, 2026 | Cadrenal Therapeutics Inc. | Open-market sale | −2,127 | $3.00 | $6,381 |
| Jun 23, 2026 | Cadrenal Therapeutics Inc. | Open-market sale | −2,277 | $3.20 | $7,286 |
| Jun 22, 2026 | Cadrenal Therapeutics Inc. | Open-market sale | −9,167 | $3.55 | $32,543 |
| Jun 17, 2026 | Cadrenal Therapeutics Inc. | Open-market sale | −513 | $3.16 | $1,621 |
| Jun 16, 2026 | Cadrenal Therapeutics Inc. | Open-market sale | −3,613 | $3.18 | $11,489 |
| Jun 15, 2026 | Cadrenal Therapeutics Inc. | Open-market sale | −3,666 | $3.58 | $13,124 |
| Jun 12, 2026 | Cadrenal Therapeutics Inc. | Open-market sale | −12,996 | $3.94 | $51,204 |
| Jun 11, 2026 | Cadrenal Therapeutics Inc. | Open-market sale | −1,462 | $4.12 | $6,023 |
| Jun 10, 2026 | Cadrenal Therapeutics Inc. | Open-market sale | −3,500 | $4.21 | $14,735 |
| Jun 9, 2026 | Cadrenal Therapeutics Inc. | Open-market sale | −12,992 | $4.06 | $52,748 |
| Jun 8, 2026 | Cadrenal Therapeutics Inc. | Open-market sale | −5,893 | $4.38 | $25,811 |
| Jun 5, 2026 | Cadrenal Therapeutics Inc. | Open-market sale | −2,064 | $4.42 | $9,123 |
| Jun 4, 2026 | Cadrenal Therapeutics Inc. | Open-market sale | −3,898 | $4.41 | $17,190 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.